Cargando…

Infections Caused by Carbapenem-Resistant Enterobacteriaceae: An Update on Therapeutic Options

Carbapenems are considered as last-resort antibiotics for the treatment of infections caused by multidrug-resistant Gram-negative bacteria. With the increasing use of carbapenems in clinical practice, the emergence of carbapenem-resistant pathogens now poses a great threat to human health. Currently...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sheu, Chau-Chyun, Chang, Ya-Ting, Lin, Shang-Yi, Chen, Yen-Hsu, Hsueh, Po-Ren
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6363665/ https://www.ncbi.nlm.nih.gov/pubmed/30761114 http://dx.doi.org/10.3389/fmicb.2019.00080

Ejemplares similares

Carbapenem-Resistant Enterobacteriaceae Infections: Taiwan Aspects
por: Jean, Shio-Shin, et al.
Publicado: (2018)

Update on infections caused by Stenotrophomonas maltophilia with particular attention to resistance mechanisms and therapeutic options
por: Chang, Ya-Ting, et al.
Publicado: (2015)

Treatment Options for Carbapenem-Resistant Enterobacteriaceae Infections
por: Morrill, Haley J., et al.
Publicado: (2015)

Carbapenem-resistant enterobacteriaceae: analyzing knowledge and practice in healthcare providers
por: Thibodeau, Evangeline, et al.
Publicado: (2014)

Characteristics of Carbapenem-Resistant Enterobacteriaceae in Ready-to-Eat Vegetables in China
por: Liu, Bao-Tao, et al.
Publicado: (2018)

Antimicrobial Activity of Lactobacillus Species Against Carbapenem-Resistant Enterobacteriaceae
por: Chen, Chi-Chung, et al.
Publicado: (2019)

Therapeutic Options for the Treatment of Carbapenem-resistant Enterobacteriaceae Infections: Hope in the Times of Hype and Despair
por: Ansari, Abdul S
Publicado: (2021)

ChromID(®) CARBA Agar Fails to Detect Carbapenem-Resistant Enterobacteriaceae With Slightly Reduced Susceptibility to Carbapenems
por: Pauly, Natalie, et al.
Publicado: (2020)

In Vitro Activity of Neomycin, Streptomycin, Paromomycin and Apramycin against Carbapenem-Resistant Enterobacteriaceae Clinical Strains
por: Hu, Ya, et al.
Publicado: (2017)

Editorial: Carbapenem-resistant Enterobacteriaceae in the Asia Pacific and beyond, volume II
por: Tang, Yi-Wei
Publicado: (2023)

2410. Clinical Outcomes Associated With Various Treatment Options for Infections Caused by Carbapenem-Resistant Enterobacteriaceae
por: Bandali, Aiman, et al.
Publicado: (2018)

2416. Risk Factors and Outcomes of Bacteremia Caused by Carbapenem-Resistant Enterobacteriaceae Compared With Carbapenem Susceptible Enterobacteriaceae
por: Mahmood, Syed Faisal
Publicado: (2018)

Assessment of combination therapy in BALB/c mice injected with carbapenem-resistant Enterobacteriaceae strains
por: Salloum, Noor A., et al.
Publicado: (2015)

Editorial: Emerging Enterobacteriaceae Infections: Antibiotic Resistance and Novel Treatment Options
por: Matar, Ghassan M.
Publicado: (2017)

Global Threat of Carbapenem-Resistant Gram-Negative Bacteria
por: Jean, Shio-Shin, et al.
Publicado: (2022)

Carbonyl Cyanide m-Chlorophenylhydrazine (CCCP) Reverses Resistance to Colistin, but Not to Carbapenems and Tigecycline in Multidrug-Resistant Enterobacteriaceae
por: Osei Sekyere, John, et al.
Publicado: (2017)

Resistance Pattern of Carbapenem on Enterobacteriaceae
por: Pokharel, Khilasa, et al.
Publicado: (2018)

Carbapenem-Nonsusceptible Enterobacteriaceae in Taiwan
por: Wang, Jann-Tay, et al.
Publicado: (2015)

Treatment for infections with carbapenem-resistant Enterobacteriaceae: what options do we still have?
por: Yamamoto, Michele, et al.
Publicado: (2014)

Characterization of Carbapenem-Resistant Enterobacteriaceae Cultured From Retail Meat Products, Patients, and Porcine Excrement in China
por: Feng, Jie, et al.
Publicado: (2021)

A retrospective study on molecular epidemiology trends of carbapenem resistant Enterobacteriaceae in a teaching hospital in Malaysia
por: Kong, Zhi Xian, et al.
Publicado: (2022)

Gut microbiota alterations in critically Ill patients with carbapenem-resistant Enterobacteriaceae colonization: A clinical analysis
por: Baek, Moon Seong, et al.
Publicado: (2023)

Socioeconomic Burden of Bloodstream Infections Caused by Carbapenem-Resistant Enterobacteriaceae
por: Zhu, Yunying, et al.
Publicado: (2021)

Genetic Diversity of Carbapenem-Resistant Enterobacteriaceae (CRE) Clinical Isolates From a Tertiary Hospital in Eastern China
por: Miao, Minhui, et al.
Publicado: (2019)

Emerging Carbapenem-Resistant Enterobacteriaceae Infection, Its Epidemiology and Novel Treatment Options: A Review
por: Tilahun, Mihret, et al.
Publicado: (2021)

Vital Signs: Carbapenem-Resistant Enterobacteriaceae
por: Jacob, Jesse T., et al.
Publicado: (2013)

The Role of Trimethoprim/Sulfamethoxazole in the Treatment of Infections Caused by Carbapenem-Resistant Enterobacteriaceae
por: Luterbach, Courtney L, et al.
Publicado: (2018)

Systematic review of carbapenem-resistant Enterobacteriaceae causing neonatal sepsis in China
por: Ding, Yijun, et al.
Publicado: (2019)

Hospital-Acquired Infections Caused by Carbapenem-Resistant Enterobacteriaceae: An Observational Study
por: Aldali, Hamzah J., et al.
Publicado: (2023)

Comparison of the Performance of Phenotypic Methods for the Detection of Carbapenem-Resistant Enterobacteriaceae (CRE) in Clinical Practice
por: Zhang, Zhijie, et al.
Publicado: (2022)

Evaluation of Resistance Mechanisms in Carbapenem-Resistant Enterobacteriaceae
por: Alizadeh, Naser, et al.
Publicado: (2020)

Concurrent Resistance to Carbapenem and Colistin Among Enterobacteriaceae Recovered From Human and Animal Sources in Nigeria Is Associated With Multiple Genetic Mechanisms
por: Ngbede, Emmanuel O., et al.
Publicado: (2021)

Cefmetazole for bacteremia caused by ESBL-producing enterobacteriaceae comparing with carbapenems
por: Fukuchi, Takahiko, et al.
Publicado: (2016)

Deaths Attributable to Carbapenem-Resistant Enterobacteriaceae Infections
por: Falagas, Matthew E., et al.
Publicado: (2014)

Factors associated with acquisition of carbapenem-resistant Enterobacteriaceae
por: Lavagnoli, Lilian Silva, et al.
Publicado: (2017)

369 Outcomes of Patients with Carbapenem-Resistant Enterobacteriaceae
por: Raybould, Jillian, et al.
Publicado: (2014)

Emerging superbugs: The threat of Carbapenem Resistant Enterobacteriaceae
por: Dong, Le Thanh, et al.
Publicado: (2020)

Intestinal Dysbiosis in Carriers of Carbapenem-Resistant Enterobacteriaceae
por: Korach-Rechtman, Hila, et al.
Publicado: (2020)

Antibiotic Susceptibility Patterns for Carbapenem-Resistant Enterobacteriaceae
por: Armin, Shahnaz, et al.
Publicado: (2023)

Drug resistance analysis of three types of avian-origin carbapenem-resistant Enterobacteriaceae in Shandong Province, China
por: Su, Yaxin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_a8u8sgr06ek6ev780ci0gr20oq